FIA
MRNA icon

FNY Investment Advisers’s Moderna MRNA Stock Holding History

FNY Investment Advisers’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Buy
+10
New +$517 ﹤0.01% 977
2025
Q4 		– Sell
-341
Closed -$8K – 1248
2025
Q3 		$8K Buy
341
+307
+903% +$8.56K ﹤0.01% 841
2025
Q2 		$0 Sell
34
-361
-91% -$9.51K ﹤0.01% 1104
2025
Q1 		$11K Sell
395
-1,854
-82% -$65.8K 0.01% 480
2024
Q4 		$93K Buy
2,249
+2,234
+14,893% +$107K 0.05% 276
2024
Q3 		$1K Buy
+15
New +$1.38K ﹤0.01% 628
2024
Q1 		– Sell
-15
Closed -$1K – 774
2023
Q4 		$1K Buy
+15
New +$1.26K ﹤0.01% 431
2023
Q3 		– Sell
-497
Closed -$60K – 691
2023
Q2 		$60K Sell
497
-11
-2% -$1.47K 0.08% 149
2023
Q1 		$78K Buy
+508
New +$83.8K 0.09% 147
2021
Q4 		– Sell
-143
Closed -$55K – 715
2021
Q3 		$55K Buy
143
+31
+28% +$11.4K 0.03% 327
2021
Q2 		$26K Sell
112
-592
-84% -$106K 0.01% 508
2021
Q1 		$92K Buy
704
+223
+46% +$32.3K 0.03% 328
2020
Q4 		$50K Buy
+481
New +$48.7K 0.01% 387
2020
Q2 		– Sell
-18,675
Closed -$559K – 527
2020
Q1 		$559K Buy
+18,675
New +$430K 0.43% 52
2019
Q3 		– Sell
-21,500
Closed -$314K – 1057
2019
Q2 		$314K Buy
+21,500
New +$462K 0.09% 121
2019
Q1 		– Sell
-1,500
Closed -$22K – 855
2018
Q4 		$22K Buy
+1,500
New +$24.7K 0.01% 354

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

FNY Investment Advisers's MRNA Position: Q2 2026 in Review

FNY Investment Advisers opened a new position in Moderna (MRNA) in Q2 2026: 10 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #977 among its holdings. This is a return to the name: FNY Investment Advisers previously reported a position in MRNA as recently as Q3 2025.

FNY Investment Advisers first reported a position in MRNA in Q4 2018 and has held it in 16 quarters since. The position peaked at $559K in Q1 2020. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • FNY Investment Advisers held 10 shares of Moderna worth $0 as of Q2 2026.
  • Moderna was a new FNY Investment Advisers position in Q2 2026.
  • Moderna made up ﹤0.01% of FNY Investment Advisers's portfolio in Q2 2026, its #977 holding.
  • FNY Investment Advisers first reported a position in Moderna in Q4 2018 and has held it in 16 quarters since.
  • FNY Investment Advisers's Moderna position peaked at $559K in Q1 2020.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.